ABE1342

Sigma-Aldrich

Anti-ZBTB4 (KAISO-L1)

from rabbit

别名:
Zinc finger and BTB domain-containing protein 4, KAISO-like zinc finger protein 1, KAISO-L1
eCl@ss:
32160702
NACRES:
NA.41
价格与库存信息目前不能提供

biological source

rabbit

Quality Level

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human

species reactivity (predicted by homology)

monkey (based on 100% sequence homology), bovine (based on 100% sequence homology), rat (based on 100% sequence homology)

packaging

antibody small pack of 25 μg

application(s)

immunohistochemistry: suitable (paraffin)
western blot: suitable

isotype

IgG

NCBI accession no.

UniProt accession no.

Gene Information

human ... ZBTB4(57659)

General description

Zinc finger and BTB domain-containing protein 4 (UniProt: Q9P1Z0; also known as KAISO-like zinc finger protein 1, KAISO-L1, ZBTB4) is encoded by the ZBTB4 (also known as KIAA1538) gene (Gene ID: 57659) in human. ZBTB4 is an epigenetic regulator that localizes at pericentromeric heterochromatin. It is shown to be an essential component in maintaining genomic stability in mammals. It serves as a transcriptional repressor with bimodal DNA-binding specificity. It represses transcription in a methyl-CpG-dependent manner and binds with a higher affinity to methylated CpG dinucleotides in the consensus sequence 5′-CGCG-3′, but can also bind to the non-methylated consensus sequence 5′-CTGCNA-3′ (also known as the consensus kaiso binding site). ZBTB4 contains six C2H2-type zinc-finger domains and two proline-rich regions (aa 435-536 and 610-654). Its BTB (Broad-Complex, Tramtrack and Bric a brac) domain is localized in the amino acids 30-152. It is shown to be is frequently downregulated in cancer. ZBTB4 is phosphorylated by HIPK2 (Homeodomain Interacting Protein Kinase 2) and phosphorylation reduces its stability and triggers its degradation in response to DNA damage. (Ref.: Roussel-Gervais A., et al. (2017). Cancer Res; 77(1); 62-73; Yamada, D., et al (2009). Oncogene. 28(27); 2535-2544).

Specificity

This rabbit polyclonal antibody detects Zinc finger and BTB domain-containing protein 4 (KAISO-L1) in human cells. It targets an epitope within 17 amino acids from the internal region.

Immunogen

KLH-conjugated linear peptide corresponding to 17 amino acids from the internal region of human Zinc finger and BTB domain-containing protein 4.

Application

Immunohistochemistry Analysis: A 1:250 dilution from a representative lot detected ZBTB4 (KAISO-L1) in human fallopian tube and human cervical cancer tissue sections.
Research Category
Epigenetics & Nuclear Function
Anti-ZBTB4 (KAISO-L1), Cat. No. ABE1342, is a highly specific rabbit polyclonal antibody that targets Zinc finger and BTB domain-containing protein 4 and has been tested for use in Immunohistochemistry (Paraffin) and in Western Blotting.

Quality

Evaluated by Western Blotting in PC3 cell lysate.

Western Blotting Analysis: 2 µg/mL of this antibody detected ZBTB4 (KAISO-L1) in PC3 cell lysate.

Target description

~105 kDa observed. Uncharacterized bands may be observed in some lysate(s).

Physical form

Format: Purified
Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Affinity Purified

Storage and Stability

Stable for 1 year at 2-8°C from date of receipt.

Other Notes

Concentration: Please refer to lot specific datasheet.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

WGK Germany

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。